Search and Track the Federal Register
Department or Agency:
Show:
Regulations Filed: All Dates
Between and
Full Text (optional):

[Federal Register: October 28, 2009 (Volume 74, Number 207)]
[Notices]               
[Page 55586]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28oc09-105]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    By Notice dated June 22, 2009, and published in the Federal 
Register on June 29, 2009, (74 FR 31049), Noramco, Inc., Division of 
Ortho-McNeil, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as an importer of Tapentadol (9780), a basic class of 
controlled substance listed in schedule II.
    The company plans to import an intermediate of the basic class 
listed for the bulk manufacture of Tapentadol which it will distribute 
to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Noramco, Inc. to import the basic class of controlled 
substance is consistent with the public interest and with United States 
obligations under international treaties, conventions, or protocols in 
effect on May 1, 1971, at this time. DEA has investigated Noramco, Inc. 
to ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 
Sec.  958(a), and in accordance with 21 CFR 1301.34, the above named 
company is granted registration as an importer of the basic class of 
controlled substance listed.

    Dated: October 16, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-25906 Filed 10-27-09; 8:45 am]

BILLING CODE 4410-09-P